… Sormani reports personal consulting fees from Merck Serono, Biogen Idec, Teva, Actelion,
Synthon, and Novartis, outside the submitted work. She serves as an editorial board member …

Neuroaxonal damage is the pathological substrate of permanent disability in various
neurological disorders. Reliable quantification and longitudinal follow-up of such damage are …

The role of MRI in the assessment of multiple sclerosis (MS) goes far beyond the diagnostic
process. MRI techniques can be used as regular monitoring to help stage patients with MS …

Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

The clinical use of MRI in patients with multiple sclerosis (MS) has advanced markedly over
the past few years. Technical improvements and continuously emerging data from clinical …

Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—relapsing-remitting,
secondary progressive, and primary progressive—for patient care, research, …

Background Adjuvant chemotherapy with anthracyclines improves disease-free and overall
survival compared with non–anthracycline-based adjuvant chemotherapy regimens in the …

Objective: To assess the time course of brain atrophy and the difference across clinical
subtypes in multiple sclerosis (MS). Methods: The percent brain volume change (PBVC) was …

Objective To report the 5-year risk and to identify risk factors for the development of a seminal
acute or progressive clinical event in a multi-national cohort of asymptomatic subjects …